These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3271317)

  • 1. [Changes in class II (HLA-D) antigen expression on T-lymphocytes in the recipients of allogeneic kidney transplants].
    Nowaczyk M; Małdyk-Durlik M; Morzycka-Michalik M; Modlińska M; Lao M; Górski A
    Pol Arch Med Wewn; 1988; 80(2-3):83-7. PubMed ID: 3271317
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-class II antibodies in kidney transplant patients.
    Rebibou JM; Bittencourt MC; Ducloux D; Chabod J; Thévenin C; Chalopin JM; Hervé P; Tiberghien P
    Transplant Proc; 2000 Dec; 32(8):2748-9. PubMed ID: 11134785
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of expression of histocompatibility antigens class II (HLA-D) and interleukin-2 receptor in the process of rejection of transplanted organs. I].
    Nowaczyk M
    Pol Arch Med Wewn; 1989; 82(4-6):190-4. PubMed ID: 2518392
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune monitoring after renal transplantation. I. HLA-D expression on T cells from renal allograft recipients.
    Nowaczyk M; Górski A; Modlińska M; Rancewicz Z; Bukowska J; Ołdakowska U; Morzycka-Michalik M; Lao M
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):291-6. PubMed ID: 1667260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of protective genes in the HLA system on renal graft survival.
    Mikłaszewicz A; Giedrys-Kalemba S; Teodorczyk U; Hałasa J; Goertz K; Zieliński S; Ostrowski M; Kostyrka R; Lapis J; Kulig G; Kulig T; Kruszewski T; Kozłowski M; Lewiński D; Grzywacz B; Grzywacz M; Kuprjanowicz L
    Transplant Proc; 2000 Sep; 32(6):1337-8. PubMed ID: 10995972
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of class I and class II HLA antigens in cadaveric renal transplantation.
    Sengar DP; Couture RA; Raman S; Jindal SL; Lazarovits AI
    Transplant Proc; 1987 Aug; 19(4):3422-5. PubMed ID: 3303509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of expression of histocompatibility antigens class II (HLA-D) and interleukin-2 receptor in the process of rejection of transplanted organs].
    Nowaczyk M
    Pol Arch Med Wewn; 1991 Oct; 86(4):263-6. PubMed ID: 1813879
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA class II and IL-2R expression in acute vascular rejection of human kidney allografts.
    von Willebrand E; Salmela K; Isoniemi H; Taskinen E; Krogerus L; Häyry P
    Transplant Proc; 1992 Feb; 24(1):303-4. PubMed ID: 1539286
    [No Abstract]   [Full Text] [Related]  

  • 10. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.
    Reinsmoen NL; Kaufman D; Matas A; Sutherland DE; Najarian JS; Bach FH
    Transplantation; 1990 Nov; 50(5):783-90. PubMed ID: 2146784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
    Carta P; Di Maria L; Caroti L; Buti E; Antognoli G; Minetti EE
    Transplant Rev (Orlando); 2015 Jul; 29(3):135-8. PubMed ID: 25976621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and T lymphocytes expressing HLA-D region-encoded gene products in rejected renal transplants.
    Fellström B; Larsson E; Claesson K; Tufveson G; Wahlberg J; Klareskog L
    Transplant Proc; 1988 Jun; 20(3):372-4. PubMed ID: 3132767
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
    Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
    Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term success rate of HLA-DRB1 compatible kidney transplants.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi M; Ohshima S; Ikoma F
    Transplant Proc; 1993 Dec; 25(6):3056-9. PubMed ID: 8266451
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys.
    Bonneville M; Moreau JF; Blokland E; Pool J; Charron D; Goulmy E; Soulillou JP
    Transplant Proc; 1988 Apr; 20(2):193-5. PubMed ID: 3284038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.